Elvitegravir

Published October 15, 2012
Susa Coffey, MD
http://hivinsite.ucsf.edu/InSite?page=ar-07-02
Selected Reference
8. Canducci F, Ceresola ER, Boeri E, et al. Cross-resistance profile of the novel integrase inhibitor dolutegravir (S/GSK1349572) using clonal viral variants selected in patients failing raltegravir. J Infect Dis. 2011 Dec 1;204(11):1811-5.